These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 27181226

  • 1. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C, Mowat F, Sayed H, Mehad M, Duluc L, Piper S, Luhmann U, Nandi M, Kelly P, Smith A, Ali R, Leiper J, Bainbridge J.
    Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
    [Abstract] [Full Text] [Related]

  • 2. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, Chen Y.
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [Abstract] [Full Text] [Related]

  • 3. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK, Dasari C, Duscharla D, Supriya B, Ram NS, Surekha MV, Kumar JM, Ummanni R.
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [Abstract] [Full Text] [Related]

  • 4. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B, Nandi M, Kelly P, Wojciak-Stothard B, Fleming I, Leiper J.
    Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
    [Abstract] [Full Text] [Related]

  • 5. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
    Dowsett L, Piper S, Slaviero A, Dufton N, Wang Z, Boruc O, Delahaye M, Colman L, Kalk E, Tomlinson J, Birdsey G, Randi AM, Leiper J.
    Circulation; 2015 Jun 23; 131(25):2217-25. PubMed ID: 25910799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 11. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 20; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 12. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
    Kami Reddy KR, Dasari C, Vandavasi S, Natani S, Supriya B, Jadav SS, Sai Ram N, Kumar JM, Ummanni R.
    ACS Comb Sci; 2019 Apr 08; 21(4):241-256. PubMed ID: 30673277
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma.
    Kinker KG, Gibson AM, Bass SA, Day BP, Deng J, Medvedovic M, Figueroa JA, Hershey GK, Chen W.
    PLoS One; 2014 Apr 08; 9(1):e85148. PubMed ID: 24465497
    [Abstract] [Full Text] [Related]

  • 14. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW, Xiong Y, He P.
    Nitric Oxide; 2007 Feb 08; 16(1):94-103. PubMed ID: 16979918
    [Abstract] [Full Text] [Related]

  • 15. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
    Zhang P, Hu X, Xu X, Chen Y, Bache RJ.
    Arterioscler Thromb Vasc Biol; 2011 Apr 08; 31(4):890-7. PubMed ID: 21212404
    [Abstract] [Full Text] [Related]

  • 16. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR.
    Am J Physiol Heart Circ Physiol; 2008 Aug 08; 295(2):H816-25. PubMed ID: 18567702
    [Abstract] [Full Text] [Related]

  • 17. Asymmetric dimethylarginine contributes to retinal neovascularization of diabetic retinopathy through EphrinB2 pathway.
    Du MR, Yan L, Li NS, Wang YJ, Zhou T, Jiang JL.
    Vascul Pharmacol; 2018 Sep 08; 108():46-56. PubMed ID: 29777874
    [Abstract] [Full Text] [Related]

  • 18. Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
    Zhang P, Fassett JT, Zhu G, Li J, Hu X, Xu X, Chen Y, Bache RJ.
    Vasc Med; 2017 Jun 08; 22(3):179-188. PubMed ID: 28145161
    [Abstract] [Full Text] [Related]

  • 19. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N, Craig JE.
    PLoS One; 2010 Mar 01; 5(3):e9462. PubMed ID: 20209122
    [Abstract] [Full Text] [Related]

  • 20. Endothelial TWIST1 promotes pathological ocular angiogenesis.
    Li J, Liu CH, Sun Y, Gong Y, Fu Z, Evans LP, Tian KT, Juan AM, Hurst CG, Mammoto A, Chen J.
    Invest Ophthalmol Vis Sci; 2014 Nov 20; 55(12):8267-77. PubMed ID: 25414194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.